Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Obesity11722 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A03700 | 33898960 | JHEP Rep | Treatment of NAFLD with intermittent calorie restriction or low-carb high-fat diet - a randomised controlled trial. | 2021 | Details |
| A03704 | 33897616 | Front Endocrinol (Lausanne) | Glucagon-Like Peptide-1 Receptor Agonists for Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: A Meta-Analysis. | 2021 | Details |
| A03705 | 33897464 | Front Physiol | Free Fatty Acid Receptors as Mediators and Therapeutic Targets in Liver Disease. | 2021 | Details |
| A03709 | 33895783 | Int J Obes (Lond) | Lampaya Medicinalis Phil. decreases lipid-induced triglyceride accumulation and proinflammatory markers in human hepatocytes and fat body of Drosophila melanogaster. | 2021 | Details |
| A03717 | 33894100 | Liver Int | Diagnostic accuracy of fibrosis tests in children with non-alcoholic fatty liver disease: A systematic review. | 2021 | Details |
| A03725 | 33891332 | FASEB J | Silencing of STE20-type kinase MST3 in mice with antisense oligonucleotide treatment ameliorates diet-induced nonalcoholic fatty liver disease. | 2021 | Details |
| A03727 | 33889132 | Front Endocrinol (Lausanne) | Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes. | 2021 | Details |
| A03730 | 33887358 | J Hepatol | Hepatic lipidomic remodeling in severe obesity manifests with steatosis and does not evolve with non-alcoholic steatohepatitis. | 2021 | Details |
| A03733 | 33885048 | Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub | Effect of bariatric surgery on fatty liver disease in obese patients: A prospective one year follow-up study. | 2021 | Details |
| A03734 | 33883996 | Int J Endocrinol | Circulating Prokineticin 2 Levels Are Increased in Children with Obesity and Correlated with Insulin Resistance. | 2021 | Details |
| A03737 | 33883445 | Curr Opin Lipidol | Nonalcohol fatty liver disease: balancing supply and utilization of triglycerides. | 2021 | Details |
| A03749 | 33878988 | Expert Rev Gastroenterol Hepatol | Liver-spleen axis in nonalcoholic fatty liver disease. | 2021 | Details |
| A03750 | 33878875 | Arch Iran Med | Hepatic Steatosis and Fibrosis in Type 2 Diabetes: A Risk-Based Approach to Targeted Screening. | 2021 | Details |
| A03752 | 33878116 | PLoS One | Leaf powder supplementation of Senna alexandrina ameliorates oxidative stress, inflammation, and hepatic steatosis in high-fat diet-fed obese rats. | 2021 | Details |
| A03755 | 33876811 | Food Funct | The role of iron homeostasis in adipocyte metabolism. | 2021 | Details |
| A03756 | 33875327 | Trends Endocrinol Metab | RIPK1 targeting protects against obesity and atherosclerosis. | 2021 | Details |
| A03758 | 33872860 | Mol Metab | Iron aggravates hepatic insulin resistance in the absence of inflammation in a novel db/db mouse model with iron overload. | 2021 | Details |
| A03760 | 33872605 | J Lipid Res | Carboxylesterase 2 proteins are efficient diglyceride and monoglyceride lipases possibly implicated in metabolic disease. | 2021 | Details |
| A03767 | 33871081 | J Gastroenterol Hepatol | Interplay between non-alcoholic fatty liver disease and cardiovascular risk in an asymptomatic general population. | 2021 | Details |
| A03768 | 33870623 | Mol Nutr Food Res | Nicotinamide Protects Against Diet-Induced Body Weight Gain, Increases Energy Expenditure, and Induces White Adipose Tissue Beiging. | 2021 | Details |
| A03770 | 33869312 | Front Cardiovasc Med | The Roles and Pharmacological Effects of FGF21 in Preventing Aging-Associated Metabolic Diseases. | 2021 | Details |
| A03771 | 33869077 | Front Cell Infect Microbiol | The Role of Gut Microbiota in Duodenal-Jejunal Bypass Surgery-Induced Improvement of Hepatic Steatosis in HFD-Fed Rats. | 2021 | Details |
| A03777 | 33867441 | Eur J Gastroenterol Hepatol | Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease. | 2021 | Details |
| A03779 | 33867228 | Eur J Intern Med | Adiponectin involved in portal flow hepatic extraction of 13C-methacetin in obesity and non-alcoholic fatty liver. | 2021 | Details |
| A03781 | 33865909 | J Hepatol | Muscle fat content is strongly associated with NASH: A longitudinal study in patients with morbid obesity. | 2021 | Details |
| A03783 | 33865049 | J Pharm Biomed Anal | Serum untargeted metabolomics delineates the metabolic status in different subtypes of non-alcoholic fatty liver disease. | 2021 | Details |
| A03789 | 33862461 | Biochem Biophys Res Commun | Canagliflozin ameliorates hepatic fat deposition in obese diabetic mice: Role of prostaglandin E2. | 2021 | Details |
| A03791 | 33862225 | Clin Gastroenterol Hepatol | Maternal and Perinatal Risk Factors for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review. | 2021 | Details |
| A03796 | 33861449 | Adv Exp Med Biol | Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease. | 2021 | Details |
| A03797 | 33861444 | Adv Exp Med Biol | Medicinal Plants and Phytochemicals Regulating Insulin Resistance and Glucose Homeostasis in Type 2 Diabetic Patients: A Clinical Review. | 2021 | Details |
| A03798 | 33861434 | Adv Exp Med Biol | The Effect of Curcumin Phytosome on the Treatment of Patients with Non-alcoholic Fatty Liver Disease: A Double-Blind, Randomized, Placebo-Controlled Trial. | 2021 | Details |
| A03802 | 33860214 | ACS Pharmacol Transl Sci | Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese Mice. | 2021 | Details |
| A03803 | 33860199 | ACS Pharmacol Transl Sci | Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice. | 2021 | Details |
| A03804 | 33860188 | ACS Pharmacol Transl Sci | Pyruvate Dehydrogenase as a Therapeutic Target for Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03813 | 33859820 | Biomed Rep | Effects of obesity and 10 weeks metformin treatment on liver steatosis. | 2021 | Details |
| A03815 | 33859314 | Sci Rep | Extra virgin olive oil improved body weight and insulin sensitivity in high fat diet-induced obese LDLr-/-.Leiden mice without attenuation of steatohepatitis. | 2021 | Details |
| A03819 | 33857552 | Adv Drug Deliv Rev | Cellular protein markers, therapeutics, and drug delivery strategies in the treatment of diabetes-associated liver fibrosis. | 2021 | Details |
| A03820 | 33857511 | Int J Biol Macromol | Walnut green husk polysaccharides prevent obesity, chronic inflammatory responses, nonalcoholic fatty liver disease and colonic tissue damage in high-fat diet fed rats. | 2021 | Details |
| A03827 | 33856023 | Hum Mol Genet | Allele-specific variation at APOE increases nonalcoholic fatty liver disease and obesity but decreases risk of Alzheimer's disease and myocardial infarction. | 2021 | Details |
| A03829 | 33855386 | Minerva Endocrinol (Torino) | Relationship between plasma 12,13-diHOME level and nonalcoholic fatty liver disease in patients with type 2 diabetes and obesity. | 2021 | Details |
| A03830 | 33855376 | Minerva Surg | NAFLD: a multi-faceted morbid spectrum with uncertain diagnosis and complicated management. | 2021 | Details |
| A03831 | 33854987 | J Hepatocell Carcinoma | NAFLD-Associated HCC: Progress and Opportunities. | 2021 | Details |
| A03834 | 33853848 | BMJ Open Diabetes Res Care | Interleukin-6 mediated exercise-induced alleviation of adiposity and hepatic steatosis in mice. | 2021 | Details |
| A03839 | 33852514 | Eur J Gastroenterol Hepatol | Incidences of hypothyroidism and autoimmune thyroiditis are increased in patients with nonalcoholic fatty liver disease. | 2021 | Details |
| A03842 | 33851592 | Wiad Lek | THE ROLE OF ZONULIN IN THE DEVELOPMENT OF LIVER FIBROSIS IN OBESE ADOLESCENTS. | 2021 | Details |
| A03843 | 33851458 | Hepatology | Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge. | 2021 | Details |
| A03851 | 33847141 | J Am Heart Assoc | Cardiac Morphology, Function, and Hemodynamics in Patients With Morbid Obesity and Nonalcoholic Steatohepatitis. | 2021 | Details |
| A03853 | 33846949 | Obes Surg | Gastric Bypass Compared with Sleeve Gastrectomy for Nonalcoholic Fatty Liver Disease: a Systematic Review and Meta-analysis. | 2021 | Details |
| A03855 | 33844928 | Child Obes | Omega-3 Use for the Treatment of Hypertriglyceridemia, Low High-Density Lipoprotein Cholesterol Levels, and Nonalcoholic Fatty Liver Disease in Children with Obesity. | 2021 | Details |
| A03856 | 33844769 | Rev Med Chil | [The impact on metabolic and reproductive diseases of low-carbohydrate and ketogenic diets]. | 2020 | Details |
| A03857 | 33844174 | Obes Surg | Evolution of Non-alcoholic Fatty Liver Disease (NAFLD) Biomarkers in Response to Weight Loss 1 Year After Bariatric Surgery-a Post Hoc Analysis of the FibroTest Prospective Study. | 2021 | Details |
| A03858 | 33844015 | Toxicol Sci | Perfluorooctanesulfonic Acid (PFOS) Thwarts the Beneficial Effects of Calorie Restriction and Metformin. | 2021 | Details |
| A03859 | 33841891 | Obes Sci Pract | Dynamics of hepatic steatosis resolution and changes in gut microbiome with weight loss in nonalcoholic fatty liver disease. | 2021 | Details |
| A03864 | 33840072 | Curr Obes Rep | The Role of Mitochondrial Adaptation and Metabolic Flexibility in the Pathophysiology of Obesity and Insulin Resistance: an Updated Overview. | 2021 | Details |
| A03868 | 33838994 | Nutr Metab Cardiovasc Dis | Does a high intake of green leafy vegetables protect from NAFLD? Evidence from a large population study. | 2021 | Details |
| A03876 | 33836983 | J Clin Lipidol | Managing cardiometabolic risk factors across a woman's lifespan: A lipidologist's perspective. | 2021 | Details |
| A03881 | 33833974 | Pediatr Gastroenterol Hepatol Nutr | Vitamin D Effect on Ultrasonography and Laboratory Indices and Biochemical Indicators in the Blood: an Interventional Study on 12 to 18-Year-Old Children with Fatty Liver. | 2021 | Details |
| A03883 | 33833538 | Diabetes Metab Syndr Obes | The Association Between Different Obesity Phenotypes and Liver Fibrosis Scores in Elderly Individuals with Fatty Liver in Taiwan. | 2021 | Details |
| A03884 | 33833450 | Nat Rev Cardiol | Global epidemiology of dyslipidaemias. | 2021 | Details |
| A03886 | 33833347 | Sci Rep | Sulforaphane ameliorates lipid profile in rodents: an updated systematic review and meta-analysis. | 2021 | Details |
| A03887 | 33832846 | Z Med Phys | Towards detection of inflammation in adipose tissue: Microscopic field simulations to estimate water signal properties. | 2021 | Details |
| A03888 | 33832643 | Maturitas | Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations. | 2021 | Details |
| A03889 | 33832488 | Cell Commun Signal | Mild exacerbation of obesity- and age-dependent liver disease progression by senolytic cocktail dasatinib + quercetin. | 2021 | Details |
| A03891 | 33831691 | Phytomedicine | Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats. | 2021 | Details |
| A03908 | 33823088 | J Pediatr Endocrinol Metab | Early menarche is associated with insulin-resistance and non-alcoholic fatty liver disease in adolescents with obesity. | 2021 | Details |
| A03910 | 33822497 | Int J Med Mushrooms | Bioactive Components and Possible Activities of Medicinal Mushrooms in Alleviating the Pathogenesis of Nonalcoholic Fatty Liver Disease (Review). | 2021 | Details |
| A03911 | 33822317 | Hepatol Int | Clinical and economic burden of nonalcoholic steatohepatitis in Saudi Arabia, United Arab Emirates and Kuwait. | 2021 | Details |
| A03913 | 33821832 | Clin Transl Gastroenterol | Nonalcoholic Fatty Liver Disease in Lean Subjects: Associations With Metabolic Dysregulation and Cardiovascular Risk-A Single-Center Cross-Sectional Study. | 2021 | Details |
| A03915 | 33820503 | Mini Rev Med Chem | Mechanism of Natural Drugs on Nonalcoholic Fatty Liver Disease. | 2021 | Details |
| A03919 | 33817364 | Heliyon | Inhaled exposure to air fresheners aggravated liver injury in a murine model of nonalcoholic fatty acid liver disease. | 2021 | Details |
| A03920 | 33817272 | Open Life Sci | Relationship of FTO gene variations with NAFLD risk in Chinese men. | 2020 | Details |
| A03921 | 33816145 | World J Transplant | Noninvasive markers of liver steatosis and fibrosis after liver transplantation - Where do we stand? | 2021 | Details |
| A03922 | 33816022 | Cureus | Nonalcoholic Fatty Liver Disease and Fibrosis Risk in Patients With Obstructive Sleep Apnea: A Retrospective Analysis. | 2021 | Details |
| A03925 | 33815675 | World J Hepatol | Papaya improves non-alcoholic fatty liver disease in obese rats by attenuating oxidative stress, inflammation and lipogenic gene expression. | 2021 | Details |
| A03928 | 33815296 | Front Endocrinol (Lausanne) | Cardio-Metabolic Indices and Metabolic Syndrome as Predictors of Clinical Severity of Gastroenteropancreatic Neuroendocrine Tumors. | 2021 | Details |
| A03929 | 33815271 | Front Endocrinol (Lausanne) | Cholesterol Accumulation as a Driver of Hepatic Inflammation Under Translational Dietary Conditions Can Be Attenuated by a Multicomponent Medicine. | 2021 | Details |
| A03931 | 33813683 | Obes Surg | Comparison of Liver Recovery After Sleeve Gastrectomy and Roux-en-Y-Gastric Bypass. | 2021 | Details |
| A03932 | 33813462 | Wiad Lek | RATIO OF MAIN PHYLOTYPES OF GUT MICROBIOTA IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE DEPENDING ON THE BODY MASS INDEX. | 2021 | Details |
| A03935 | 33813276 | Biochem Biophys Res Commun | Hepatocytes derived increased SAA1 promotes intrahepatic platelet aggregation and aggravates liver inflammation in NAFLD. | 2021 | Details |
| A03939 | 33811619 | Eat Weight Disord | Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study. | 2021 | Details |
| A03941 | 33811369 | JPEN J Parenter Enteral Nutr | Body composition measured by bioelectrical impedance analysis is a viable alternative to magnetic resonance imaging in children with nonalcoholic fatty liver disease. | 2021 | Details |
| A03943 | 33811139 | Proc Natl Acad Sci U S A | Active p38α causes macrovesicular fatty liver in mice. | 2021 | Details |
| A03944 | 33810963 | Nutr Metab Cardiovasc Dis | Association between MBOAT7 rs641738 polymorphism and non-alcoholic fatty liver in overweight or obese children. | 2021 | Details |
| A03947 | 33810566 | Int J Mol Sci | Hepatic Senescence Accompanies the Development of NAFLD in Non-Aged Mice Independently of Obesity. | 2021 | Details |
| A03954 | 33808740 | Cancers (Basel) | A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC? | 2021 | Details |
| A03958 | 33808007 | Int J Mol Sci | Momordica cochinchinensis Aril Ameliorates Diet-Induced Metabolic Dysfunction and Non-Alcoholic Fatty Liver by Modulating Gut Microbiota. | 2021 | Details |
| A03960 | 33807699 | J Clin Med | The Role of the Transsulfuration Pathway in Non-Alcoholic Fatty Liver Disease. | 2021 | Details |
| A03961 | 33807672 | Cancers (Basel) | ARMCX3 Mediates Susceptibility to Hepatic Tumorigenesis Promoted by Dietary Lipotoxicity. | 2021 | Details |
| A03962 | 33807605 | Int J Mol Sci | Mechanisms by Which Probiotic Bacteria Attenuate the Risk of Hepatocellular Carcinoma. | 2021 | Details |
| A03963 | 33807573 | Int J Mol Sci | An Overview of the Molecular Mechanisms Contributing to Musculoskeletal Disorders in Chronic Liver Disease: Osteoporosis, Sarcopenia, and Osteoporotic Sarcopenia. | 2021 | Details |
| A03967 | 33806784 | Children (Basel) | MAFLD in Obese Children: A Challenging Definition. | 2021 | Details |
| A03968 | 33806527 | Pharmaceuticals (Basel) | The Evaluation of Drug Delivery Nanocarrier Development and Pharmacological Briefing for Metabolic-Associated Fatty Liver Disease (MAFLD): An Update. | 2021 | Details |
| A03969 | 33806428 | Cancers (Basel) | From Liver Fat to Cancer: Perils of the Western Diet. | 2021 | Details |
| A03970 | 33805912 | Int J Mol Sci | Potential of Nutraceutical Supplementation in the Modulation of White and Brown Fat Tissues in Obesity-Associated Disorders: Role of Inflammatory Signalling. | 2021 | Details |
| A03974 | 33804819 | Antioxidants (Basel) | Reduced Liver Autophagy in High-Fat Diet Induced Liver Steatosis in New Zealand Obese Mice. | 2021 | Details |
| A03976 | 33804302 | J Clin Med | The Role of Diagnostic Biomarkers, Omics Strategies, and Single-Cell Sequencing for Nonalcoholic Fatty Liver Disease in Severely Obese Patients. | 2021 | Details |
| A03977 | 33804296 | J Clin Med | From Nonalcoholic Fatty Liver Disease (NAFLD) to Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-New Terminology in Pediatric Patients as a Step in Good Scientific Direction? | 2021 | Details |
| A03979 | 33803038 | Int J Mol Sci | O-1602 Promotes Hepatic Steatosis through GPR55 and PI3 Kinase/Akt/SREBP-1c Signaling in Mice. | 2021 | Details |
| A03982 | 33802455 | Nutrients | Fructo-Oligosaccharides and Pectins Enhance Beneficial Effects of Raspberry Polyphenols in Rats with Nonalcoholic Fatty Liver. | 2021 | Details |
| A03983 | 33802047 | J Clin Med | Natural History of NAFLD. | 2021 | Details |